BD-12-CM09_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 3-[({4-[4-({[1-(2-Chlorophenyl)ethoxy]carbonyl}amino)-3-methyl-1,2-oxazol-5-yl]phenyl}methyl)sulfanyl]propanoic acid, Lysophospholipid edg2 (LPA1) Receptor Antagonists;LPAR1 antagonist;Lysophospholipid edg7 (LPA3) Receptor Antagonists;LPAR3 antagonist targeting LPAR1, LPAR3 (Novartis, 10367662)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10367662
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the BD-12-CM09_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPS5 ribosomal protein S5 0.572073
FAM50A family with sequence similarity 50, member A 0.398604
VPS28 vacuolar protein sorting 28 homolog (S. cerevisiae) 0.337496
CCT7 chaperonin containing TCP1, subunit 7 (eta) 0.260943
NONO non-POU domain containing, octamer-binding 0.253205
PDXK pyridoxal (pyridoxine, vitamin B6) kinase 0.247941
RPS15 ribosomal protein S15 0.24535
BLVRB biliverdin reductase B 0.201031
RPL32 ribosomal protein L32 0.201031
POLR2F polymerase (RNA) II (DNA directed) polypeptide F 0.201031
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.201031

decreased expression

Symbol Name Standardized Value
MTFR2 mitochondrial fission regulator 2 -0.244946